Ann Van Driessche

Induction of complete and molecular remissions in acute myeloid leukemia by Wilms’ tumor 1 antigen-targeted dendritic cell vaccination

Viggo Van Tendeloo, Ann Van de Velde, Ann Van Driessche et al. · Proceedings of the National Academy of Sciences · 2010 · 372 citations · Full text

Medicine, Immunology, Oncology +17

Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemia

Sébastien Anguille, Ann L. Van de Velde, Evelien Smits et al. · Blood · 2017 · 233 citations · Full text

Medicine, Immunology, Oncology +15

Clinical-grade manufacturing of autologous mature mRNA-electroporated dendritic cells and safety testing in acute myeloid leukemia patients in a phase I dose-escalation clinical trial

Ann Van Driessche, Ann L. R. Van de Velde, Griet Nijs et al. · Cytotherapy · 2009 · 114 citations · Full text

Life Sciences, Immunology, Oncology +17

Messenger RNA Electroporation of Human Monocytes, Followed by Rapid In Vitro Differentiation, Leads to Highly Stimulatory Antigen-Loaded Mature Dendritic Cells

Peter Ponsaerts, Glenn Van den Bosch, Nathalie Cools et al. · The Journal of Immunology · 2002 · 57 citations

Medicine, Biomedical Sciences, Immunology +17

mRNA-electroporated mature dendritic cells retain transgene expression, phenotypical properties and stimulatory capacity after cryopreservation

Peter Ponsaerts, Nathalie Cools, Ann Van Driessche et al. · Leukemia · 2002 · 55 citations

Life Sciences, Immunology, Molecular Biology +17